Skip to content
★ Sign in to follow
AY

Alexander Y. Tokman

Board Director
Director
Total declarations
63
Companies
2
▲ Purchases (41 ops.)
€204k
▼ Sales (1 ops.)
€7,334

Latest filing published 04 Mar 2026 for ENDRA Life Sciences Inc..

Filing timeline

BuySale
Alexander Y. Tokman

Insider track record

Disclosed buys
41
Disclosed sells
1
Signal history

Closed purchases

Market purchases
41
Positive at T+90
56%
Median T+90
+5.9%

Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Nov 2022 · 1441 days ago · €1,649
    -72.5%
    Entry US$6,125.00 · Close at T+365 US$1,683.50
  • Filed 24 Aug 2022 · 1537 days ago · €5,232
    -81.8%
    Entry US$10,570.00 · Close at T+365 US$1,925.00
  • Filed 17 May 2022 · 1636 days ago · €19k
    -68.9%
    Entry US$8,050.00 · Close at T+365 US$2,502.50
  • Filed 14 Dec 2016 · 3616 days ago · €47k
    +40.5%
    Entry US$18.15 · Close at T+365 US$25.50
  • Filed 19 Nov 2013 · 4737 days ago · €20k
    +31.8%
    Entry US$1.32 · Close at T+365 US$1.74

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alexander Y. Tokman: trading record in brief

This profile gathers the share dealings of Alexander Y. Tokman across 2 companies, led by Microvision, Inc. and ENDRA Life Sciences Inc. Over a trading history stretching from 9 August 2006 to 2 March 2026, the count stands at 63 filings.

On the open market, the record shows 41 purchases worth €204k and 1 sale worth €7,334. On balance, insiders were net buyers of €197k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 21 share grants.

Half of the purchases are above €1,454 and half below. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 9 purchases old enough to measure, the stock rose over the following 90 days in 56% of cases; the median change was +5.9%. They describe history only and say nothing certain about the share price ahead.

On 4 March 2026 came the latest disclosure, a share grant in ENDRA Life Sciences Inc. The latest purchase dates back some time: it was published 1,441 days ago, on 28 November 2022. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Alexander Y. Tokman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations63 total

25 of 63 declarations